Correlation Between Oracle and Pharmadrug

Can any of the company-specific risk be diversified away by investing in both Oracle and Pharmadrug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oracle and Pharmadrug into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oracle and Pharmadrug, you can compare the effects of market volatilities on Oracle and Pharmadrug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oracle with a short position of Pharmadrug. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oracle and Pharmadrug.

Diversification Opportunities for Oracle and Pharmadrug

-0.05

Correlation Coefficient

Oracle  Pharmadrug

Good diversification

The 3 months correlation between Oracle and Pharmadrug is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Oracle and Pharmadrug in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmadrug and Oracle is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oracle are associated (or correlated) with Pharmadrug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmadrug has no effect on the direction of Oracle i.e., Oracle and Pharmadrug go up and down completely randomly.

Pair Corralation between Oracle and Pharmadrug

Given the investment horizon of 90 days Oracle is expected to under-perform the Pharmadrug. But the stock apears to be less risky and, when comparing its historical volatility, Oracle is 5.0 times less risky than Pharmadrug. The stock trades about -0.07 of its potential returns per unit of risk. The Pharmadrug is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  0.95  in Pharmadrug on December 30, 2024 and sell it today you would lose (0.13) from holding Pharmadrug or give up 13.68% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.77%
Values	Daily Returns

Oracle  vs.  Pharmadrug

Oracle

Risk-Adjusted Performance

Very Weak

Over the last 90 days Oracle has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pharmadrug

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmadrug are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Pharmadrug reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oracle and Pharmadrug

The main advantage of trading using opposite Oracle and Pharmadrug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oracle position performs unexpectedly, Pharmadrug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmadrug will offset losses from the drop in Pharmadrug's long position.

The idea behind Oracle and Pharmadrug pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.